The Effect of Corticotrophin (ACTH) in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the effect of the utilization of two doses of
corticotrophin ( ACTH) as a treatment in patients with early onset rheumatoid arthritis as an
alternative to conventional steroid therapy by evaluating the change from baseline in the
clinical findings as well as the structural findings on Magnetic Resonance Imaging (MRI).
Corticotrophin (ACTH) may prevent the well documented structural progression damage in RA
patients using disease-modifying antirheumatic drug (DMARD) therapy alone.